Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cordonnier

Showing results (1061-1070 of 1,173) with videos related to

Pageof 118
Sort By:
Leukemia|August 18, 1999
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)X Thomas, P Fenaux, H Dombret, et al.
Annals of Neurology|June 6, 2025
Intravenous Glyburide in Medical and Endovascular-Treated Large-Core Stroke: A Subgroup Analysis of the CHARM Randomized Clinical TrialW Taylor Kimberly, Jeffrey L Saver, Bruce C V Campbell, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 23, 2017
Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous ThrombolyticsRéza Behrouz, Jaime Masjuán-Vallejo, Rocío Vera, et al.
Annals of Neurology|September 27, 2016
Disruption of a miR-29 binding site leading to COL4A1 upregulation causes pontine autosomal dominant microangiopathy with leukoencephalopathyEdgard Verdura, Dominique Hervé, Françoise Bergametti, et al.
Journal of Neurology|February 14, 2024
Cerebral microbleeds and risk of symptomatic hemorrhagic transformation following mechanical thrombectomy for large vessel ischemic strokeRémi Agbonon, Géraud Forestier, Nicolas Bricout, et al.
Journal of Medicinal Chemistry|January 16, 2019
Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell ModelSabine Depauw, Mélanie Lambert, Samy Jambon, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 14, 2019
Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0Andreas Charidimou, Matthew P Frosch, Rustam Al-Shahi Salman, et al.
Journal of Nephrology|January 10, 2020
Tubulointerstitial damage and interstitial immune cell phenotypes are useful predictors for renal survival and relapse in antineutrophil cytoplasmic antibody-associated vasculitisLaura Bitton, Cyrille Vandenbussche, Nicolas Wayolle, et al.
Journal of the American Society of Nephrology : JASN|August 27, 2005
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitationsMarc A Pohl, Samuel Blumenthal, Daniel J Cordonnier, et al.
Presse Medicale (Paris, France : 1983)|August 1, 2002
[Mycologic surveillance of the environment for preventive invasive aspergillosis. Proposals for standardization of the methodologies and implementation]J P Gangneux, J L Poirot, O Morin, et al.
Pageof 118

Showing results (1061-1070 of 1,173) with videos related to

Sort By:
Pageof 118
Leukemia|August 18, 1999
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)X Thomas, P Fenaux, H Dombret, et al.
Annals of Neurology|June 6, 2025
Intravenous Glyburide in Medical and Endovascular-Treated Large-Core Stroke: A Subgroup Analysis of the CHARM Randomized Clinical TrialW Taylor Kimberly, Jeffrey L Saver, Bruce C V Campbell, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 23, 2017
Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous ThrombolyticsRéza Behrouz, Jaime Masjuán-Vallejo, Rocío Vera, et al.
Annals of Neurology|September 27, 2016
Disruption of a miR-29 binding site leading to COL4A1 upregulation causes pontine autosomal dominant microangiopathy with leukoencephalopathyEdgard Verdura, Dominique Hervé, Françoise Bergametti, et al.
Journal of Neurology|February 14, 2024
Cerebral microbleeds and risk of symptomatic hemorrhagic transformation following mechanical thrombectomy for large vessel ischemic strokeRémi Agbonon, Géraud Forestier, Nicolas Bricout, et al.
Journal of Medicinal Chemistry|January 16, 2019
Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell ModelSabine Depauw, Mélanie Lambert, Samy Jambon, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 14, 2019
Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0Andreas Charidimou, Matthew P Frosch, Rustam Al-Shahi Salman, et al.
Journal of Nephrology|January 10, 2020
Tubulointerstitial damage and interstitial immune cell phenotypes are useful predictors for renal survival and relapse in antineutrophil cytoplasmic antibody-associated vasculitisLaura Bitton, Cyrille Vandenbussche, Nicolas Wayolle, et al.
Journal of the American Society of Nephrology : JASN|August 27, 2005
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitationsMarc A Pohl, Samuel Blumenthal, Daniel J Cordonnier, et al.
Presse Medicale (Paris, France : 1983)|August 1, 2002
[Mycologic surveillance of the environment for preventive invasive aspergillosis. Proposals for standardization of the methodologies and implementation]J P Gangneux, J L Poirot, O Morin, et al.
Pageof 118